The role of omega-3 polyunsaturated fatty acids in the prevention of contrast-induced nephropathy (CIN) in post percutaneous coronary intervention (PCI) patients
Not Applicable
- Conditions
- Renal disease.Contrast-induced nephropathy
- Registration Number
- IRCT2016041920441N4
- Lead Sponsor
- Shiraz University of Medical Sciences, international branch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Inclusion criteria included GFR more than 60 ml/min/1.73 m2; the ages of 18 to 80 years; patients undergoing elective PCI. Exclusion criteria: Pretreatment with N-acetyl cystein or intravenous vitamin C; sensitivity or tolerance to ASA or Clopidogrel or omega-3; sever adverse effects to drugs
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cystatin C. Timepoint: Baseline and 24 hours after PCI. Method of measurement: Kit.;Serum creatinine. Timepoint: Baseline and 24 hours after PCI. Method of measurement: Kit.
- Secondary Outcome Measures
Name Time Method Contrast-induced nephropathy occurrence. Timepoint: 24 hrs after PCI. Method of measurement: Based on cystatin C.